tiprankstipranks
Trending News
More News >
Arkema SA (UK) (FR:AKE)
:AKE
Advertisement

Arkema (AKE) AI Stock Analysis

Compare
29 Followers

Top Page

FR:AKE

Arkema

(LSE:AKE)

Rating:64Neutral
Price Target:
€65.00
▲(4.92% Upside)
Arkema's overall stock score is primarily influenced by its solid financial performance, despite challenges in profitability and cash flow. The technical analysis indicates a bearish trend, which weighs on the score. However, the attractive dividend yield supports the valuation, providing a balanced outlook for investors.
Positive Factors
Earnings
The earnings trend at Performance Additives is up (+15% y/y in FY-24) and had a good start to 2025.
Price Target
Upside to Price Target (%) 25.8.
Negative Factors
Debt
Net debt increased y/y to €3.24bn (FY-23: €2.9bn) with net debt/EBITDA at 2.1x.
Demand
The company highlighted weak demand at the start of the year and ongoing uncertainties in acrylics.
Industry Performance
Lowering estimates on softer demand trends and weaker industry performance.

Arkema (AKE) vs. iShares MSCI France ETF (EWQ)

Arkema Business Overview & Revenue Model

Company DescriptionArkema (AKE) is a global specialty chemicals and advanced materials company headquartered in France. It operates through three main segments: High Performance Materials, Industrial Specialties, and Coating Solutions. Arkema's core products include advanced polymers, adhesive solutions, and specialty chemicals that serve a diverse range of industries such as automotive, construction, electronics, and consumer goods. The company is committed to innovation and sustainability, focusing on developing solutions that address environmental challenges.
How the Company Makes MoneyArkema generates revenue primarily through the sale of its specialty chemicals and materials across various market sectors. The company has a diverse revenue model that includes direct sales to manufacturers and end-users, as well as partnerships with key players in the industries it serves. Significant revenue streams come from its High Performance Materials segment, which produces advanced materials used in high-growth applications like electric vehicles and renewable energy. Additionally, Arkema benefits from strategic collaborations and acquisitions that enhance its product offerings and market reach, contributing positively to its earnings.

Arkema Financial Statement Overview

Summary
Arkema's 2024 financial performance shows resilience with stable revenue but declining profitability and cash flow generation. The balance sheet remains solid with a strong equity base, though increased leverage and reduced return on equity pose challenges.
Income Statement
72
Positive
Arkema's income statement reflects moderate stability with a slight revenue growth of 0.31% in 2024. The gross profit margin is stable at approximately 20.3% for 2024, however, the net profit margin decreased to 3.71%, indicating reduced profitability. The EBIT and EBITDA margins have slightly decreased, suggesting a need for cost management improvements.
Balance Sheet
68
Positive
The balance sheet exhibits a healthy equity ratio of 49.5%, implying a strong equity base. The debt-to-equity ratio increased to 0.60, indicating increased leverage. Return on equity declined to 4.70%, showing reduced efficiency in generating returns from equity.
Cash Flow
65
Positive
Cash flow analysis reveals a significant decline in free cash flow by 43.24% in 2024, raising concerns about cash generation. The operating cash flow to net income ratio is robust at 3.17, but the free cash flow to net income ratio dropped to 1.00, reflecting less cash available for expansion or shareholder returns.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.54B9.51B11.55B9.52B7.88B
Gross Profit1.94B1.96B2.58B2.14B1.55B
EBITDA1.31B1.33B1.82B2.27B1.19B
Net Income354.00M402.00M965.00M1.31B332.00M
Balance Sheet
Total Assets15.21B14.52B13.51B12.30B10.71B
Cash, Cash Equivalents and Short-Term Investments2.01B2.04B1.59B2.29B1.63B
Total Debt4.55B4.28B3.26B2.76B2.80B
Total Liabilities7.45B7.06B6.17B5.95B5.48B
Stockholders Equity7.53B7.20B7.30B6.30B5.19B
Cash Flow
Free Cash Flow353.00M622.00M766.00M152.00M510.00M
Operating Cash Flow1.12B1.26B1.50B915.00M1.11B
Investing Cash Flow-940.00M-1.35B-2.34B473.00M-458.00M
Financing Cash Flow-207.00M516.00M168.00M-652.00M-535.00M

Arkema Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price61.95
Price Trends
50DMA
62.04
Negative
100DMA
62.28
Negative
200DMA
67.54
Negative
Market Momentum
MACD
-0.46
Negative
RSI
51.42
Neutral
STOCH
72.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Neutral. The current price of 61.95 is above the 20-day moving average (MA) of 61.64, below the 50-day MA of 62.04, and below the 200-day MA of 67.54, indicating a neutral trend. The MACD of -0.46 indicates Negative momentum. The RSI at 51.42 is Neutral, neither overbought nor oversold. The STOCH value of 72.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:AKE.

Arkema Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
€1.61B16.96
1.37%11.99%20.45%
69
Neutral
€103.11B30.0513.92%1.83%1.46%12.62%
64
Neutral
€4.62B21.343.56%5.90%0.19%-37.62%
64
Neutral
€3.71B10.3716.47%9.51%-15.12%-10.10%
57
Neutral
€6.92B6.143.91%3.65%28.24%-62.06%
47
Neutral
€1.85B50.11-5.29%6.54%-7.71%-451.19%
45
Neutral
€1.46B108.77-7.36%2.87%-6.91%-222.35%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:AKE
Arkema
61.95
-13.78
-18.20%
FR:ERA
Eramet SA
52.55
-19.11
-26.67%
FR:VK
Vallourec
15.78
3.36
27.06%
FR:NK
IMERYS SA
22.18
-6.57
-22.84%
FR:AI
Air Liquide
180.22
17.75
10.92%
FR:CBE
Robertet SA Cert.d'Invest. Em.87
730.00
24.70
3.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 12, 2025